1,351
Views
0
CrossRef citations to date
0
Altmetric
Articles

Prognostic factors and outcomes of infant acute lymphoblastic leukemia (ALL), hypodiploid ALL, and mixed-phenotype acute leukemia (MPAL) in Canada: a report from CYP-C

, , , , , , , , & show all
Pages 3208-3216 | Received 10 Jun 2022, Accepted 23 Aug 2022, Published online: 06 Sep 2022

References

  • Hunger SP, Mullighan CG. Acute lymphoblastic leukemia in children. N Engl J Med. 2015;373(16):1541–1552.
  • Hunger SP, Loh ML, Whitlock JA, et al. Children’s oncology group’s 2013 blueprint for research: acute lymphoblastic leukemia. Pediatr Blood Cancer. 2013;60(6):957–963.
  • Raetz EA, Bhatla T. Where do we stand in the treatment of relapsed acute lymphoblastic leukemia? Hematology Am Soc Hematol Educ Program. 2012;2012:129–136.
  • Biondi A, Cimino G, Pieters R, et al. Biological and therapeutic aspects of infant leukemia. Blood. 2000;96(1):24–33.
  • Pui CH, Rebora P, Schrappe M, et al. Outcome of children with hypodiploid acute lymphoblastic leukemia: a retrospective multinational study. J Clin Oncol. 2019;37(10):770–779.
  • Orgel E, Alexander TB, Wood BL, et al. Mixed-phenotype acute leukemia: a cohort and consensus research strategy from the children’s oncology group acute leukemia of ambiguous lineage task force. Cancer. 2020;126(3):593–601.
  • Public Health Agency of Canada. Cancer in Young People in Canada: a report from the enhanced childhood cancer surveillance. Winnipeg (Canada): Public Health Agency of Canada; 2017. p. 58. https://www.canada.ca/fr/sante-canada/services/publications/science-recherche-et-donnees/cancer-jeunes-canada-surveillance-2017.html
  • Mitra D, Hutchings K, Shaw A, et al. Status report - the cancer in young people in Canada surveillance system. Health Promot Chronic Dis Prev Can. 2015;35(4):73–76.
  • Strahlendorf C, Pole JD, Barber R, et al. Enrolling children with acute lymphoblastic leukaemia on a clinical trial improves event-free survival: a population-based study. Br J Cancer. 2018;118(5):744–749.
  • Brown P. Treatment of infant leukemias: challenge and promise. Hematology Am Soc Hematol Educ Program. 2013;2013:596–600.
  • Pieters R, De Lorenzo P, Ancliffe P, et al. Outcome of infants younger than 1 year with acute lymphoblastic leukemia treated with the interfant-06 protocol: results from an international phase III randomized study. J Clin Oncol. 2019;37(25):2246–2256.
  • Pieters R, Schrappe M, De Lorenzo P, et al. A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (interfant-99): an observational study and a multicentre randomised trial. Lancet. 2007;370(9583):240–250.
  • Schultz KR, Devidas M, Bowman WP, et al. Philadelphia chromosome-negative very high-risk acute lymphoblastic leukemia in children and adolescents: results from children’s oncology group study AALL0031. Leukemia. 2014;28(4):964–967.
  • McNeer JL, Devidas M, Dai Y, et al. Hematopoietic stem-cell transplantation does not improve the poor outcome of children with hypodiploid acute lymphoblastic leukemia: a report from children’s oncology group. J Clin Oncol. 2019;37(10):780–789.
  • Hrusak O, de Haas V, Stancikova J, et al. International cooperative study identifies treatment strategy in childhood ambiguous lineage leukemia. Blood. 2018;132(3):264–276.
  • Maruffi M, Sposto R, Oberley MJ, et al. Therapy for children and adults with mixed phenotype acute leukemia: a systematic review and meta-analysis. Leukemia. 2018;32(7):1515–1528.